rat anti-cd11b Search Results


98
Miltenyi Biotec cd11b c fitc
Cd11b C Fitc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+anti-cd11b/CD11b%2Fc+Antibody%2C+anti-rat%2C+REAfinity/pmc06896275-34-35-41
Average 98 stars, based on 1 article reviews
cd11b c fitc - by Bioz Stars, 2026-09
98/100 stars
  Buy from Supplier

96
Bio-Rad mouse cd11b
Figure 5. EP4 receptor conditional knock-out in microglia enhances inflammation and amyloid deposition early at 5 months in APPSwe-PS1E9 (APPS) mice. Microglial EP4 receptor conditional knock-out (EP4-cKO) 5 month female and 9 month male APPS or nontransgenic (Non-tg) mice were generated using the <t>CD11b-Cre;</t> EP4 lox/lox strategy. A, qRT-PCR from hippocampal RNA demonstrates elevated CCL3 expression in APPS EP4-cKO mice at 5 months but not 9 months, and a trend toward increased IL-1 in 5 month APPS-EP4cKO mice. B, LC/ESI/MS/MS analysis of cortical lysates demonstrates elevated -ketoaldehyde adduct levels in young APPS EP4-cKO mice at 5 months. A40 (C) and (D) A42 ELISAs from guanidine-extracted cerebral cortex demonstrate increased A levels in EP4-cKO mice in 5 month but not 9 month APPS-EP4cKO mice. E, Immunostaining for 6E10-positive A plaques (arrows) and quantification of A plaque area in the hippocampus (F) demonstrates increased A plaque area and density in APPS EP4-cKO mice at 5 months of age. G, Congo Red staining for plaque cores (white arrows) and quantification of Congo Red-positive area in the hippocampus and cerebral cortex (H) demonstrates increased dense-core plaque percentage area in APPS EP4-cKO mice (A–H; n 4–11 mice per group). *p 0.05 (unpaired t test). **p 0.01 (unpaired t test). ***p 0.0001 (unpaired t test). I, J, Quantitative Western analysis of PSD-95 demonstrates significant decrease in 5 month (n 4/genotype; p 0.05) and in 9 month cohorts (n 3–5 mice per genotype; ANOVA p 0.032, post hoc Bonferroni multiple comparison. *p 0.05, APP-PS1;Cd11bCre; EP4 / versus APP-PS1;Cd11Cre;EP4 lox/lox, with conditional deletion of EP4 in APP-PS1 mice.
Mouse Cd11b, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+anti-cd11b/Rat+anti+Mouse+CD11b/10__1523_slash_jneurosci__0410___14__2014-64-32-35
Average 96 stars, based on 1 article reviews
mouse cd11b - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

96
Bio-Rad anti cd11b ox 42
Figure 5. EP4 receptor conditional knock-out in microglia enhances inflammation and amyloid deposition early at 5 months in APPSwe-PS1E9 (APPS) mice. Microglial EP4 receptor conditional knock-out (EP4-cKO) 5 month female and 9 month male APPS or nontransgenic (Non-tg) mice were generated using the <t>CD11b-Cre;</t> EP4 lox/lox strategy. A, qRT-PCR from hippocampal RNA demonstrates elevated CCL3 expression in APPS EP4-cKO mice at 5 months but not 9 months, and a trend toward increased IL-1 in 5 month APPS-EP4cKO mice. B, LC/ESI/MS/MS analysis of cortical lysates demonstrates elevated -ketoaldehyde adduct levels in young APPS EP4-cKO mice at 5 months. A40 (C) and (D) A42 ELISAs from guanidine-extracted cerebral cortex demonstrate increased A levels in EP4-cKO mice in 5 month but not 9 month APPS-EP4cKO mice. E, Immunostaining for 6E10-positive A plaques (arrows) and quantification of A plaque area in the hippocampus (F) demonstrates increased A plaque area and density in APPS EP4-cKO mice at 5 months of age. G, Congo Red staining for plaque cores (white arrows) and quantification of Congo Red-positive area in the hippocampus and cerebral cortex (H) demonstrates increased dense-core plaque percentage area in APPS EP4-cKO mice (A–H; n 4–11 mice per group). *p 0.05 (unpaired t test). **p 0.01 (unpaired t test). ***p 0.0001 (unpaired t test). I, J, Quantitative Western analysis of PSD-95 demonstrates significant decrease in 5 month (n 4/genotype; p 0.05) and in 9 month cohorts (n 3–5 mice per genotype; ANOVA p 0.032, post hoc Bonferroni multiple comparison. *p 0.05, APP-PS1;Cd11bCre; EP4 / versus APP-PS1;Cd11Cre;EP4 lox/lox, with conditional deletion of EP4 in APP-PS1 mice.
Anti Cd11b Ox 42, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+anti-cd11b/Mouse+anti+Rat+CD11b/10__1074_slash_jbc__m102829200-86-58-60
Average 96 stars, based on 1 article reviews
anti cd11b ox 42 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

93
Cedarlane mouse mab anti cd11b
Figure 5. EP4 receptor conditional knock-out in microglia enhances inflammation and amyloid deposition early at 5 months in APPSwe-PS1E9 (APPS) mice. Microglial EP4 receptor conditional knock-out (EP4-cKO) 5 month female and 9 month male APPS or nontransgenic (Non-tg) mice were generated using the <t>CD11b-Cre;</t> EP4 lox/lox strategy. A, qRT-PCR from hippocampal RNA demonstrates elevated CCL3 expression in APPS EP4-cKO mice at 5 months but not 9 months, and a trend toward increased IL-1 in 5 month APPS-EP4cKO mice. B, LC/ESI/MS/MS analysis of cortical lysates demonstrates elevated -ketoaldehyde adduct levels in young APPS EP4-cKO mice at 5 months. A40 (C) and (D) A42 ELISAs from guanidine-extracted cerebral cortex demonstrate increased A levels in EP4-cKO mice in 5 month but not 9 month APPS-EP4cKO mice. E, Immunostaining for 6E10-positive A plaques (arrows) and quantification of A plaque area in the hippocampus (F) demonstrates increased A plaque area and density in APPS EP4-cKO mice at 5 months of age. G, Congo Red staining for plaque cores (white arrows) and quantification of Congo Red-positive area in the hippocampus and cerebral cortex (H) demonstrates increased dense-core plaque percentage area in APPS EP4-cKO mice (A–H; n 4–11 mice per group). *p 0.05 (unpaired t test). **p 0.01 (unpaired t test). ***p 0.0001 (unpaired t test). I, J, Quantitative Western analysis of PSD-95 demonstrates significant decrease in 5 month (n 4/genotype; p 0.05) and in 9 month cohorts (n 3–5 mice per genotype; ANOVA p 0.032, post hoc Bonferroni multiple comparison. *p 0.05, APP-PS1;Cd11bCre; EP4 / versus APP-PS1;Cd11Cre;EP4 lox/lox, with conditional deletion of EP4 in APP-PS1 mice.
Mouse Mab Anti Cd11b, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+anti-cd11b/Anti-Mouse+CD11b%2C+FITC+(Clone+M1%2F70%2E15)+(rat+IgG2b)/pmc02835177-394-43-51
Average 93 stars, based on 1 article reviews
mouse mab anti cd11b - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

91
Cedarlane cl042b
Antibodies used in the study
Cl042b, supplied by Cedarlane, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+anti-cd11b/Anti-Rat+CD11b%2Fc+Biotin+(Clone+OX-42)+(mouse+IgG2a)/pmc07694354-9-9-7
Average 91 stars, based on 1 article reviews
cl042b - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier

86
Cedarlane ox 42
Antibodies used in the study
Ox 42, supplied by Cedarlane, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+anti-cd11b/Anti-Rat+CD11b%2Fc+Purified+(Clone+OX-42)+(mouse+IgG2a)/pmc02777780-102-8-9
Average 86 stars, based on 1 article reviews
ox 42 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

93
Cedarlane ihc mac1
Antibodies used in the study
Ihc Mac1, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+anti-cd11b/Anti-Mouse+CD11b+%2C+Biotin+(Clone+M1%2F70%2E15)+(rat+IgG2b)/pmc11061606-198-6-8
Average 93 stars, based on 1 article reviews
ihc mac1 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Cedarlane anti cd11b
Antibodies used in the study
Anti Cd11b, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+anti-cd11b/Anti-Mouse+CD11b%2C+PE+(Clone+M1%2F70%2E15)+(rat+IgG2b)/pmc03344944-209-4-9
Average 93 stars, based on 1 article reviews
anti cd11b - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

91
Cedarlane cd11b c
Antibodies used in the study
Cd11b C, supplied by Cedarlane, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+anti-cd11b/Anti-Rat+CD11b%2Fc+PE+(Clone+OX-42)+(mouse+IgG2a)/pmc07694354-21-4-7
Average 91 stars, based on 1 article reviews
cd11b c - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier

93
Cedarlane anti mac 1 pe cy 5 cd11b cd18 ab
Antibodies used in the study
Anti Mac 1 Pe Cy 5 Cd11b Cd18 Ab, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+anti-cd11b/Anti-Mouse+CD11b%2C+PE-Cy5+(Clone+M1%2F70%2E15)+(rat+IgG2b)/pmc03118960-83-0-6
Average 93 stars, based on 1 article reviews
anti mac 1 pe cy 5 cd11b cd18 ab - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Multi Sciences (Lianke) Biotech Co Ltd cd11b apc
Antibodies used in the study
Cd11b Apc, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rat+anti-cd11b/Anti-Rat+CD11b%2Fc/pm39192976-142-30-31
Average 93 stars, based on 1 article reviews
cd11b apc - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

Image Search Results


Figure 5. EP4 receptor conditional knock-out in microglia enhances inflammation and amyloid deposition early at 5 months in APPSwe-PS1E9 (APPS) mice. Microglial EP4 receptor conditional knock-out (EP4-cKO) 5 month female and 9 month male APPS or nontransgenic (Non-tg) mice were generated using the CD11b-Cre; EP4 lox/lox strategy. A, qRT-PCR from hippocampal RNA demonstrates elevated CCL3 expression in APPS EP4-cKO mice at 5 months but not 9 months, and a trend toward increased IL-1 in 5 month APPS-EP4cKO mice. B, LC/ESI/MS/MS analysis of cortical lysates demonstrates elevated -ketoaldehyde adduct levels in young APPS EP4-cKO mice at 5 months. A40 (C) and (D) A42 ELISAs from guanidine-extracted cerebral cortex demonstrate increased A levels in EP4-cKO mice in 5 month but not 9 month APPS-EP4cKO mice. E, Immunostaining for 6E10-positive A plaques (arrows) and quantification of A plaque area in the hippocampus (F) demonstrates increased A plaque area and density in APPS EP4-cKO mice at 5 months of age. G, Congo Red staining for plaque cores (white arrows) and quantification of Congo Red-positive area in the hippocampus and cerebral cortex (H) demonstrates increased dense-core plaque percentage area in APPS EP4-cKO mice (A–H; n 4–11 mice per group). *p 0.05 (unpaired t test). **p 0.01 (unpaired t test). ***p 0.0001 (unpaired t test). I, J, Quantitative Western analysis of PSD-95 demonstrates significant decrease in 5 month (n 4/genotype; p 0.05) and in 9 month cohorts (n 3–5 mice per genotype; ANOVA p 0.032, post hoc Bonferroni multiple comparison. *p 0.05, APP-PS1;Cd11bCre; EP4 / versus APP-PS1;Cd11Cre;EP4 lox/lox, with conditional deletion of EP4 in APP-PS1 mice.

Journal: Journal of Neuroscience

Article Title: Suppression of Alzheimer-Associated Inflammation by Microglial Prostaglandin-E2 EP4 Receptor Signaling

doi: 10.1523/jneurosci.0410-14.2014

Figure Lengend Snippet: Figure 5. EP4 receptor conditional knock-out in microglia enhances inflammation and amyloid deposition early at 5 months in APPSwe-PS1E9 (APPS) mice. Microglial EP4 receptor conditional knock-out (EP4-cKO) 5 month female and 9 month male APPS or nontransgenic (Non-tg) mice were generated using the CD11b-Cre; EP4 lox/lox strategy. A, qRT-PCR from hippocampal RNA demonstrates elevated CCL3 expression in APPS EP4-cKO mice at 5 months but not 9 months, and a trend toward increased IL-1 in 5 month APPS-EP4cKO mice. B, LC/ESI/MS/MS analysis of cortical lysates demonstrates elevated -ketoaldehyde adduct levels in young APPS EP4-cKO mice at 5 months. A40 (C) and (D) A42 ELISAs from guanidine-extracted cerebral cortex demonstrate increased A levels in EP4-cKO mice in 5 month but not 9 month APPS-EP4cKO mice. E, Immunostaining for 6E10-positive A plaques (arrows) and quantification of A plaque area in the hippocampus (F) demonstrates increased A plaque area and density in APPS EP4-cKO mice at 5 months of age. G, Congo Red staining for plaque cores (white arrows) and quantification of Congo Red-positive area in the hippocampus and cerebral cortex (H) demonstrates increased dense-core plaque percentage area in APPS EP4-cKO mice (A–H; n 4–11 mice per group). *p 0.05 (unpaired t test). **p 0.01 (unpaired t test). ***p 0.0001 (unpaired t test). I, J, Quantitative Western analysis of PSD-95 demonstrates significant decrease in 5 month (n 4/genotype; p 0.05) and in 9 month cohorts (n 3–5 mice per genotype; ANOVA p 0.032, post hoc Bonferroni multiple comparison. *p 0.05, APP-PS1;Cd11bCre; EP4 / versus APP-PS1;Cd11Cre;EP4 lox/lox, with conditional deletion of EP4 in APP-PS1 mice.

Article Snippet: Immunocytochemistry for mouse EP4 was performed using a chicken antibody directed against the mouse EP4 receptor (1:500), described and validated in (Liang et al., 2011), and a rat monoclonal antibody directed against mouse CD11b (1:500, AbD Serotec).

Techniques: Knock-Out, Generated, Quantitative RT-PCR, Expressing, Tandem Mass Spectroscopy, Immunostaining, Staining, Western Blot, Comparison

Antibodies used in the study

Journal: BMC Molecular and Cell Biology

Article Title: Transcriptome and proteome profiling reveal complementary scavenger and immune features of rat liver sinusoidal endothelial cells and liver macrophages

doi: 10.1186/s12860-020-00331-9

Figure Lengend Snippet: Antibodies used in the study

Article Snippet: CD11b/c Biotin (OX-42) , CD11b/c, CR3 , Cedarlane , CL042B , 2 μg/ml.

Techniques: Concentration Assay, Flow Cytometry, Control, Staining, FACS